Terms: = Lung cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Prognosis
24 results:
1. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
[TBL] [Abstract] [Full Text] [Related]
2. [Imbalance of lymphoid cells in peripheral blood maintains the immunosuppression and promotes the development of lung adenocarcinoma].
Guo H; Zang L; Yang X; Wu Y; Ma J; Shi W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Aug; 39(8):729-736. PubMed ID: 37515340
[TBL] [Abstract] [Full Text] [Related]
3. A case report of pulmonary hepatoid adenocarcinoma: promoting standardized diagnosis and treatment of the rare disease.
Xu K; Gao J; Feng L; Fang Y; Tang X
Front Immunol; 2023; 14():1203876. PubMed ID: 37292208
[TBL] [Abstract] [Full Text] [Related]
4. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological Features and prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
[No Abstract] [Full Text] [Related]
6. MicroRNA-449a Inhibits Triple Negative Breast cancer by Disturbing DNA Repair and Chromatid Separation.
Vajen B; Bhowmick R; Greiwe L; Schäffer V; Eilers M; Reinkens T; Stalke A; Schmidt G; Fiedler J; Thum T; DeLuca DS; Hickson ID; Schlegelberger B; Illig T; Skawran B
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563522
[TBL] [Abstract] [Full Text] [Related]
7. Poor prognosis of male triple-positive breast cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract] [Full Text] [Related]
8. [A pulmonary tumor that racks our brains!].
Tauziède-Espariat A; Kleinmann P; Benali A; Bitton L; Antin G; Hasty L; Georges O
Ann Pathol; 2021 Sep; 41(5):486-489. PubMed ID: 33926758
[TBL] [Abstract] [Full Text] [Related]
9. Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools.
Gerratana L; Davis AA; Polano M; Zhang Q; Shah AN; Lin C; Basile D; Toffoli G; Wehbe F; Puglisi F; Behdad A; Platanias LC; Gradishar WJ; Cristofanilli M
Eur J Cancer; 2021 Jan; 143():147-157. PubMed ID: 33307492
[TBL] [Abstract] [Full Text] [Related]
10. The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas.
Prabhakaran S; Hocking A; Kim C; Hussey M; Klebe S
Hum Pathol; 2020 Nov; 105():1-8. PubMed ID: 32888937
[TBL] [Abstract] [Full Text] [Related]
11. [Neuroendocrine differentiation in breast cancer].
Kreipe HH
Pathologe; 2019 Dec; 40(Suppl 3):325-330. PubMed ID: 31781853
[TBL] [Abstract] [Full Text] [Related]
12. The Clinical Value of PELP1 for Breast cancer: A Comparison with Multiple cancers and Analysis in Breast cancer Subtypes.
Wang X; Tsang JYS; Lee MA; Ni YB; Tong JH; Chan SK; Cheung SY; To KF; Tse GM
Cancer Res Treat; 2019 Apr; 51(2):706-717. PubMed ID: 30134648
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of peripheral blood T lymphocyte surface activation markers and transcription factors in patients with early stage non-small cell lung cancer.
Rutkowski J; Cyman M; Ślebioda T; Bemben K; Rutkowska A; Gruchała M; Kmieć Z; Pliszka A; Zaucha R
Cell Immunol; 2017 Dec; 322():26-33. PubMed ID: 28939130
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
[TBL] [Abstract] [Full Text] [Related]
15. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression.
Guo S; Yang P; Jiang X; Li X; Wang Y; Zhang X; Sun B; Zhang Y; Jia Y
Oncotarget; 2017 Jan; 8(1):644-657. PubMed ID: 27893417
[TBL] [Abstract] [Full Text] [Related]
16. gata3 expression in advanced breast cancer: prognostic value and organ-specific relapse.
McCleskey BC; Penedo TL; Zhang K; Hameed O; Siegal GP; Wei S
Am J Clin Pathol; 2015 Nov; 144(5):756-63. PubMed ID: 26486740
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.
Hattori Y; Yoshida A; Yoshida M; Takahashi M; Tsuta K
Pathol Int; 2015 Jun; 65(6):286-92. PubMed ID: 25727644
[TBL] [Abstract] [Full Text] [Related]
18. Adenocarcinoma of the paraurethral glands: a case report.
Massari F; Ciccarese C; Modena A; Maines F; Segala D; Luchini C; Marcolini L; Cavicchioli F; Cavalleri S; Bria E; Brunelli M; Martignoni G; Artibani W; Tortora G
Histol Histopathol; 2014 Oct; 29(10):1295-303. PubMed ID: 24604416
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities.
Jardim DL; Conley A; Subbiah V
Orphanet J Rare Dis; 2013 Jul; 8():112. PubMed ID: 23895135
[TBL] [Abstract] [Full Text] [Related]
20. gata3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression.
Chou J; Lin JH; Brenot A; Kim JW; Provot S; Werb Z
Nat Cell Biol; 2013 Feb; 15(2):201-13. PubMed ID: 23354167
[TBL] [Abstract] [Full Text] [Related]
[Next]
